Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma

Study acronym: Uveal Melanoma
StatusNot Yet Recruiting
PhasePhase 1/2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
ReBio Pharma
1 trial monitored
See all monitored trials
Melanoma
1,093 trials monitored
See 62 trials at risk
Neoadjuvant RBP-01 in patients with primary uveal melanoma.
Trial Details
NCT Number NCT07747935
Lead Sponsor ReBio Pharma
Conditions
(from sponsor)		 Uveal Melanoma
Related terms Uveal Melanoma
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov